Trending

sickle cell

Novartis drug cuts serious complications in sickle cell disease

Novartis drug cuts serious complications in sickle cell disease

Novartis’ developmental sickle cell disease drug crizanlizumab cut occurrences of a serious complication of the disease that can

X

Novartis drug cuts serious complications in sickle cell disease

https://pharmaphorum.com/news/novartis-drug-cuts-serious-complications-in-sickle-cell-disease/

Novartis buys sickle cell biotech Selexys

Novartis buys sickle cell biotech Selexys

Swiss pharma takes option on US biotech.

X

Novartis buys sickle cell biotech Selexys

https://pharmaphorum.com/news/novartis-buys-us-biotech-selexys/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com